Researchers reveal SARS-CoV-2 distribution and relation to tissue damage in patients
COVID-19 vaccines as effective in real-world settings as in clinical trials
30 March 2021The third generation of siRNA delivery system makes RNAi therapy feasible
30 March 2021Researchers reveal SARS-CoV-2 distribution and relation to tissue damage in patients
Researchers have mapped the distribution of SARS-CoV-2, the virus that causes COVID-19, in deceased patients with the disease, and shed new light on how viral load relates to tissue damage.
